From 9621bc74b0c58c581252f415ff5724ddf0bdd6d5 Mon Sep 17 00:00:00 2001 From: FMS Date: Wed, 5 Jun 2024 10:21:07 +0200 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Annual Meeting___2024___Notas.md | 7 ++++--- 1 file changed, 4 insertions(+), 3 deletions(-) diff --git a/pages/STOP2030___Annual Meeting___2024___Notas.md b/pages/STOP2030___Annual Meeting___2024___Notas.md index d2423210..10d955db 100644 --- a/pages/STOP2030___Annual Meeting___2024___Notas.md +++ b/pages/STOP2030___Annual Meeting___2024___Notas.md @@ -1,4 +1,4 @@ -# Session 1 +# Session 0 - [[Ale]]: brief intro to all the teams. Listen about the purpose of our presence is. How many goals have already been achieved. - Help improving the delivery of tools of tools and strategies for controlling STH but also integration with other diseases. - [[Charles Mwandawiro]]: WHO Roadmap 2030. Why 2030? Efforts to control STH. We talk about elimination in 2030. It used to look quite far, but its only 6 years away. STH are ntds. @@ -16,7 +16,8 @@ - Question: within the work packages. programs will need to buy this commodity. We need to have some cost evaluation or cost-benefits. - Question: for the BTS we're working towards the <2% prevalence. Elimination as a PHproblem. We've done modeling with SEMA. Can you put the perspective of the program in the modelling (reaching below 2%) - Question: I noted that there's a mention of the drug used for female, young, girls and not boys? -- # Session 2 +- # Session 1 - [[Collins Okoyo]]: What will be done. We're concerned with data management and modelling. - Develop the case report forms (CRF) - - \ No newline at end of file + - +- \ No newline at end of file